 |
市場調査レポート
商品コード
1455146
脳深部刺激装置の世界市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別 - 産業予測、2024年～2031年Global Deep Brain Stimulation Devices Market Size, Share, Growth Analysis, By Product Type, By Application, By End-user - Industry Forecast 2024-2031 |
||||||
| 脳深部刺激装置の世界市場規模、シェア、成長分析、製品タイプ別、用途別、エンドユーザー別 - 産業予測、2024年～2031年 |
|
出版日: 2024年03月20日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
脳深部刺激装置の世界市場規模は、2022年に14億1,000万米ドルと評価され、予測期間中（2024年～2031年）のCAGRは9.29%で、2023年の15億4,000万米ドルから2031年には31億4,000万米ドルに成長する見通しです。
脳深部刺激装置の市場は、数多くの重要な検討事項により世界規模で大きく拡大しています。本態性振戦、パーキンソン病、ジストニアなどの神経疾患が一般的になるにつれて、脳深部刺激装置のニーズが高まっています。世界のヘルスケアシステムは現在、神経疾患によって大きな負担を強いられているため、脳深部刺激療法は最も効果的な治療法の選択肢の1つとなっています。脳深部刺激装置の技術は進歩し、患者の予後を改善し、応用範囲を広げています。より長持ちする充電式バッテリー、より優れた照準システム、刺激パラメータの改善といった技術革新により、脳深部刺激療法はより安全で効果的なものとなっています。脳深部刺激が効果的な治療オプションであるという患者やヘルスケア専門家の認識が高まった結果、市場は拡大しています。脳深部刺激は、生活の質の向上、薬物への依存度の低減、症状の緩和など多くの利点があるため、ますます普及しています。市場開拓は、新興国市場の有利な償還政策にも助けられています。脳深部刺激療法機器メーカーは、医療費の上昇とヘルスケア・インフラの改善により、新興国での市場シェア拡大の大きな可能性を見出しています。
目次
エグゼクティブサマリー
- 市場概要
- 運命の輪
調査手法
- 情報調達
- セカンダリおよびプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
脳深部刺激装置の世界市場：製品タイプ別
- 市場概要
- 充電式DBSデバイス
- 非充電式DBSデバイス
脳深部刺激装置の世界市場：用途別
- 市場概要
- パーキンソン病
- 本態性振戦
- ジストニア
脳深部刺激装置の世界市場：エンドユーザー別
- 市場概要
- 病院
- 外来手術センター
- 専門クリニック
脳深部刺激装置の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic plc（Ireland）
- Boston Scientific Corporation（US）
- Abbott Laboratories（US）
- LivaNova PLC（UK）
- Sapiens Neuro（US）
- Beijing PINS Medical Co., Ltd.（China）
- SceneRay Corporation（China）
- Nevro Corp.（US）
- Aleva Neurotherapeutics SA（Switzerland）
- Functional Neuromodulation Ltd.（Canada）
- NeuroPace, Inc.（US）
- Neuronetics, Inc.（US）
- Brainsway Ltd.（Israel）
- Synaptive Medical Inc.（Canada）
- Alpha Omega Engineering Ltd.（Israel）
- Nexeon MedSystems, Inc.（US）
- Autonomix Medical, Inc.（US）
- Greatbatch Medical（US）
- SceneRay Corp.（China）
- Saluda Medical Pty Ltd.（Australia）
Global Deep Brain Stimulation Devices Market size was valued at USD 1.41 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.14 billion by 2031, at a CAGR of 9.29% during the forecast period (2024-2031).
The market for deep brain stimulation devices is expanding significantly on a global scale due to numerous important considerations. The need for deep brain stimulation devices is growing as neurological conditions such essential tremor, Parkinson's disease, and dystonia become more common. Worldwide healthcare systems are now heavily burdened by neurological illnesses, which makes deep brain stimulation one of the most effective therapy choices available. Deep brain stimulation device technology has advanced, improving patient outcomes and expanding applications. Deep brain stimulation operations are now safer and more effective thanks to innovations like longer-lasting rechargeable batteries, better targeting systems, and improved stimulation parameters. The market is expanding as a result of patients' and healthcare professionals' rising awareness of deep brain stimulation as an effective therapeutic option. Deep brain stimulation is becoming more and more popular because of its many advantages, which include better quality of life, less reliance on medication, and symptom relief. Market expansion is also being aided by developed areas' advantageous reimbursement policies. Deep brain stimulation device manufacturers are seeing great potential to grow their market share in emerging economies due to rising healthcare costs and bettering healthcare infrastructure.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Deep Brain Stimulation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Deep Brain Stimulation Devices Market Segmental Analysis
Based on product type, application, end-user, and geography, the global market for deep brain stimulation devices may be divided. The market can be divided into rechargeable and non-rechargeable DBS devices based on the type of product. The market can be divided into segments according to application, such as essential tremor, dystonia, and Parkinson's disease. The market can be divided into hospitals, ambulatory surgery centers, and specialty clinics based on the end-user. The market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America based on geographic factors.
Drivers of the Global Deep Brain Stimulation Devices Market
Technological advancements in deep brain stimulation have improved patient results, increased the number of disorders that can be treated, and increased the therapy's overall efficacy and safety. Improved stimulation parameters, more accurate targeting systems, and the incorporation of sophisticated features like closed-loop systems and adaptive algorithms are examples of technological breakthroughs. These developments allow for more individualized treatment plans, improved symptom control, and fewer adverse effects.
Restraints in the Global Deep Brain Stimulation Devices Market
Because deep brain stimulation devices are intricate, expert neurosurgeons must undertake precise insertion procedures. These devices can have high costs associated with them, especially for the programming systems, leads, and hardware. The expense of the surgical treatment itself is further increased by the requirement for specialist equipment, resources in the operating room, and post-operative care. The high price makes it difficult to purchase and accessible, especially in areas with few healthcare services or insufficient insurance coverage.
Market Trends of the Global Deep Brain Stimulation Devices Market
The demand is being driven by the rising prevalence of neurological disorders: A surgical technique called deep brain stimulation (DBS) employs electrical stimulation to treat a range of neurological conditions, such as dystonia, essential tremor, and Parkinson's disease. The aging population, the rise in chronic illnesses, and the accumulation of environmental pollutants are some of the causes of this increase in prevalence. Since DBS devices are a highly successful treatment for many neurological disorders, the demand for them is being driven by the rising prevalence of these conditions.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Deep Brain Stimulation Devices Market by Product Type
- Market Overview
- Rechargeable DBS devices
- non-rechargeable DBS devices
Global Deep Brain Stimulation Devices Market by Application
- Market Overview
- Parkinson's disease
- essential tremor
- dystonia
Global Deep Brain Stimulation Devices Market by End-user
- Market Overview
- Hospitals
- ambulatory surgical centers
- and specialty clinics
Global Deep Brain Stimulation Devices Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sapiens Neuro (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beijing PINS Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SceneRay Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aleva Neurotherapeutics SA (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Functional Neuromodulation Ltd. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Neuronetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Brainsway Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synaptive Medical Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alpha Omega Engineering Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nexeon MedSystems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Autonomix Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Greatbatch Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SceneRay Corp. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Saluda Medical Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
